Trudo Lemmens

Dr. Trudo Lemmens

orcid

Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 March 2008 in PLOS Biology
Verified
Journal Article
Open access
PDF file
TCTimothy Caulfield
Timothy Caulfield
AMAmy L McGuire
Amy L McGuire
MCMildred Cho
Mildred Cho
JBJanet A Buchanan
Janet A Buchanan
MBMichael M Burgess
Michael M Burgess
MTMichael Timmons
Michael Timmons
Interest in whole-genome research has grown substantially over the past few months. This article explores the challenging ethics issues associated with this work.

1 April 2009 in Croatian Medical Journal
Verified
Journal Article
Open access
KKKarmela Krleža-Jerić
Karmela Krleža-Jerić
TLTrudo Lemmens
Trudo Lemmens

1 December 2000 in The Milbank Quarterly
Verified
Journal Article
Closed access
PDF file
TLTrudo Lemmens
Trudo Lemmens
BFBenjamin Freedman
Benjamin Freedman

1 October 1999 in Accountability in Research
Verified
Journal Article
Closed access
TLTrudo Lemmens
Trudo Lemmens
CECarl Elliott
Carl Elliott
Regulatory bodies and scholars have traditionally conceptualized biomedical research on healthy subjects in the same way as research on patients. Guidelines and regulations have portrayed payment to a healthy subject as a potential constraint, or “undue influence,”; on the subject's free consent. In this essay we suggest an alternative way of conceptualizing research on healthy subjects, which sees the basic issue not as one of undue influence but as one of justice. Healthy subjects generally enroll in research protocols not for humanitarian reasons but for the money they will receive. Many of these protocols are conducted by profit‐driven corporations. Yet current guidelines and regulations prohibit subjects from negotiating for fair payment for the risks, discomforts and inconveniences they undergo, and IRBs are not staffed adequately to monitor the subject's safety. We propose to remedy the situation by regulating payment to healthy subjects as a labor relation.


11 July 2013 in New England Journal of Medicine
Verified
Journal Article
Closed access
PDF file
RMRuth Macklin
Ruth Macklin
LSLois Shepherd
Lois Shepherd
ADAlice Dreger
Alice Dreger
AAAdrienne Asch
Adrienne Asch
FBFrancoise Baylis
Francoise Baylis
LTLeigh Turner
Leigh Turner
We are a group of physicians, bioethicists, and scholars in allied fields who agree with the Office for Human Research Protections (OHRP) that the informed-consent documents that were used in the Surfactant, Positive Pressure, and Oxygenation Randomized Trial (SUPPORT) were seriously inadequate.1 The aims of the SUPPORT study were commendable, and the study addressed important clinical issues. Nevertheless, however complex and important a study may be, the consent process must be clear enough to enable informed decision making.